{"id":"cathflo-activase","_chembl":{"chemblId":"CHEMBL1201593","moleculeType":"Enzyme"},"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Cathflo Activase","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T04:51:53.313911+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T04:52:00.308216+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Cathflo Activase","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T04:52:01.071035+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Tissue-type plasminogen activator exogenous protein","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T04:52:01.669136+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201593/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T04:52:01.572007+00:00"}},"_dailymed":{"setId":"91ecdef2-95ff-42dd-a31c-c8a09cab3ad9","title":"CATHFLO ACTIVASE (ALTEPLASE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [GENENTECH, INC.]"},"_scrapedAt":"2026-03-27T23:43:09.657Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T04:52:03.913316+00:00","fieldsConflicting":0,"overallConfidence":0.95},"trialDetails":[{"nctId":"NCT06184321","phase":"EARLY_PHASE1","title":"Alteplase Through an Indwelling Pleural Catheter for the Management of Symptomatic Septated Malignant Pleural Effusion","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2023-08-17","conditions":"Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm","enrollment":30},{"nctId":"NCT02315898","phase":"PHASE2","title":"Inhaled Tissue Plasminogen Activator for Acute Plastic Bronchitis","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2018-03-19","conditions":"Plastic Bronchitis, Protein-Losing Enteropathies, Healthy","enrollment":40},{"nctId":"NCT04806373","phase":"PHASE4","title":"Intrapleural Fibrinolytic Therapy to Enhance Chemical Pleurodesis Enhance Chemical Pleurodesis","status":"COMPLETED","sponsor":"Memorial Healthcare System","startDate":"2021-06-15","conditions":"Pleural Effusion","enrollment":27},{"nctId":"NCT05429476","phase":"PHASE3","title":"EXtending the Time Window for Thrombolysis in Posterior Circulation Stroke Without Early CT Signs","status":"COMPLETED","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2022-08-17","conditions":"Stroke, Acute Ischemic","enrollment":234},{"nctId":"NCT03581877","phase":"PHASE4","title":"Peripheral Systemic Thrombolysis Versus Catheter Directed Thrombolysis for Submassive PE","status":"ACTIVE_NOT_RECRUITING","sponsor":"Northwell Health","startDate":"2019-01-28","conditions":"Pulmonary Embolism, Pulmonary Hypertension, Thromboembolism","enrollment":31},{"nctId":"NCT02474810","phase":"NA","title":"Intensive Versus Standard Hemodialysis CVC Dysfunction Protocol","status":"COMPLETED","sponsor":"Nova Scotia Health Authority","startDate":"2013-01","conditions":"Chronic Renal Insufficiency","enrollment":35},{"nctId":"NCT05540834","phase":"PHASE2","title":"Viscoelastic Testing Guided Tissue Plasminogen Activator Treatment in Acute Respiratory Failure","status":"RECRUITING","sponsor":"South West Sydney Local Health District","startDate":"2022-05-18","conditions":"Acute Respiratory Failure, Hypercoagulability, Fibrinolysis Shutdown","enrollment":70},{"nctId":"NCT05258565","phase":"PHASE1","title":"TPA in Acute Stroke With COVID Verus Non-COVID-19 Patients","status":"COMPLETED","sponsor":"Assiut University","startDate":"2022-03-01","conditions":"Acute Ischemic Stroke","enrollment":50},{"nctId":"NCT04357730","phase":"PHASE2","title":"Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection","status":"COMPLETED","sponsor":"Denver Health and Hospital Authority","startDate":"2020-05-14","conditions":"Severe Acute Respiratory Syndrome, Respiratory Failure, Acute Respiratory Distress Syndrome","enrollment":50},{"nctId":"NCT01513759","phase":"PHASE3","title":"Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy","status":"COMPLETED","sponsor":"Boston Scientific Corporation","startDate":"2012-06-07","conditions":"Pulmonary Embolism, Acute Pulmonary Embolism, Sub-massive Pulmonary Embolism","enrollment":150},{"nctId":"NCT03988842","phase":"PHASE4","title":"Standard-dose Apixaban AFtEr Very Low-dose ThromboLYSis for Acute Intermediate-high Risk Acute Pulmonary Embolism","status":"TERMINATED","sponsor":"Victor Tapson, MD","startDate":"2019-07-25","conditions":"Pulmonary Embolism With Acute Cor Pulmonale, Pulmonary Embolism, Pulmonary Embolism With Pulmonary Infarction","enrollment":4},{"nctId":"NCT01717742","phase":"PHASE3","title":"Intrapleural DNase and Tissue Plasminogen Activator in Pediatric Empyema (DTPA Trial)","status":"COMPLETED","sponsor":"The Hospital for Sick Children","startDate":"2012-12","conditions":"Pleural Empyema","enrollment":97},{"nctId":"NCT01827046","phase":"PHASE3","title":"Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2013-12-30","conditions":"Intracerebral Hemorrhage","enrollment":499},{"nctId":"NCT01576679","phase":"PHASE3","title":"Safety and Efficacy of the Use of Tissue Plasminogen Activator (tPA) in Intra-Abdominal Collections in Children - A Prospective Study","status":"TERMINATED","sponsor":"The Hospital for Sick Children","startDate":"2012-03","conditions":"Intra-abdominal Abscess","enrollment":28},{"nctId":"NCT02002325","phase":"PHASE3","title":"THrombolysis for Acute Wake-up and Unclear-onset Strokes With Alteplase at 0.6 mg/kg Trial (THAWS)","status":"UNKNOWN","sponsor":"National Cerebral and Cardiovascular Center, Japan","startDate":"2014-05","conditions":"Stroke","enrollment":300},{"nctId":"NCT00784134","phase":"PHASE3","title":"Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2009-07","conditions":"Intraventricular Hemorrhage","enrollment":500},{"nctId":"NCT01525290","phase":"PHASE3","title":"Efficacy and Safety of MRI-based Thrombolysis in Wake-up Stroke","status":"COMPLETED","sponsor":"Universitätsklinikum Hamburg-Eppendorf","startDate":"2012-09","conditions":"Stroke","enrollment":501},{"nctId":"NCT01580839","phase":"PHASE3","title":"EXTEND (International): Extending the Time for Thrombolysis in Emergency Neurological Deficits (International)","status":"COMPLETED","sponsor":"Neuroscience Trials Australia","startDate":"2012-12-06","conditions":"Stroke","enrollment":45},{"nctId":"NCT00887328","phase":"PHASE3","title":"Extending the Time for Thrombolysis in Emergency Neurological Deficits","status":"COMPLETED","sponsor":"Neuroscience Trials Australia","startDate":"2010-06","conditions":"Stroke","enrollment":180},{"nctId":"NCT02767232","phase":"PHASE3","title":"Pediatric High-Risk Deep Venous Thrombosis Lytic Outcomes Trial","status":"WITHDRAWN","sponsor":"University of Colorado, Denver","startDate":"2018-07","conditions":"Deep Vein Thrombosis, Post-Thrombotic Syndrome, Venous Thrombosis","enrollment":""},{"nctId":"NCT02072226","phase":"PHASE3","title":"A Study of the Efficacy and Safety of Alteplase in Participants With Mild Stroke","status":"TERMINATED","sponsor":"Genentech, Inc.","startDate":"2014-05-31","conditions":"Stroke","enrollment":313},{"nctId":"NCT01591096","phase":"PHASE1","title":"Thrombolysis in Pediatric Stroke (TIPS)","status":"TERMINATED","sponsor":"Seattle Children's Hospital","startDate":"2012-10","conditions":"Stroke","enrollment":1},{"nctId":"NCT00265005","phase":"PHASE1","title":"Safety and Efficacy of Tissue Plasminogen Activator (tPA) in Neonates and Infants","status":"TERMINATED","sponsor":"University of Louisville","startDate":"2005-06","conditions":"Thrombosis","enrollment":12},{"nctId":"NCT00790335","phase":"PHASE3","title":"Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2009-11","conditions":"Deep Vein Thrombosis, Venous Thrombosis, Postphlebitic Syndrome","enrollment":692},{"nctId":"NCT00650858","phase":"PHASE2","title":"Clinical Trial on Treatment of Intraventricular Hemorrhage","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2004-02","conditions":"Intraventricular Hemorrhage","enrollment":52},{"nctId":"NCT01282242","phase":"PHASE2","title":"A Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients","status":"COMPLETED","sponsor":"Lee Schwamm","startDate":"2011-01","conditions":"Acute Stroke","enrollment":88},{"nctId":"NCT01643902","phase":"PHASE2","title":"Safety of Intravenous Thrombolytics in Stroke on Awakening","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2013-01","conditions":"Stroke","enrollment":20},{"nctId":"NCT01870492","phase":"","title":"Improving Patient Access to Stroke Therapy Study","status":"TERMINATED","sponsor":"Medical College of Wisconsin","startDate":"2014-01","conditions":"Ischemic Stroke, Transient Ischemic Attack","enrollment":500},{"nctId":"NCT01977456","phase":"PHASE2","title":"Study of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke (CLEAR-FDR)","status":"COMPLETED","sponsor":"Arthur Pancioli","startDate":"2013-09","conditions":"Stroke, Brain Infarction","enrollment":27},{"nctId":"NCT01878136","phase":"PHASE1, PHASE2","title":"Effect of Intraventricular tPA Following Aneurysmal Subarachnoid Hemorrhage","status":"WITHDRAWN","sponsor":"Rush University Medical Center","startDate":"2015-03","conditions":"Subarachnoid Hemorrhage, Cerebral Vasospasm, Cerebral Aneurysm","enrollment":""},{"nctId":"NCT02180204","phase":"PHASE2, PHASE3","title":"Tenecteplase Versus Alteplase in Ischemic Stroke Management (TALISMAN)","status":"WITHDRAWN","sponsor":"Reza Behrouz, DO","startDate":"2015-01","conditions":"Ischemic Stroke","enrollment":""},{"nctId":"NCT00224770","phase":"PHASE2","title":"Minimally Invasive Surgery and rtPA for Intracerebral Hemorrhage Evacuation","status":"COMPLETED","sponsor":"Daniel Hanley","startDate":"2005-08","conditions":"Intracerebral Hemorrhage","enrollment":141},{"nctId":"NCT02472574","phase":"PHASE2","title":"Dose-effect Relationship of Rt-PA on ICH Evacuation","status":"UNKNOWN","sponsor":"Tongji Hospital","startDate":"2015-06","conditions":"Hypertensive Intracerebral Hemorrhage","enrollment":108},{"nctId":"NCT00284739","phase":"PHASE2","title":"Alteplase for Percutaneous Treatment of Loculated Abdominopelvic Abscesses","status":"COMPLETED","sponsor":"Kaiser Permanente","startDate":"2006-02","conditions":"Abdominal Abscess, Pelvic Abscess","enrollment":20},{"nctId":"NCT01183533","phase":"PHASE2","title":"Safety of Intravenous Thrombolysis for Wake-up Stroke","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2010-07","conditions":"Ischemic Stroke","enrollment":40},{"nctId":"NCT00082355","phase":"PHASE2","title":"Low-Dose Alteplase to Treat Blood Clots in Deep Leg Veins","status":"COMPLETED","sponsor":"Richard Chang, M.D.","startDate":"2004-05","conditions":"Acute Deep Venous Thrombosis of the Lower Extremity","enrollment":30},{"nctId":"NCT00894803","phase":"PHASE2","title":"Study of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke","status":"COMPLETED","sponsor":"University of Cincinnati","startDate":"2009-07","conditions":"Ischemic Stroke, Stroke, Brain Infarction","enrollment":126},{"nctId":"NCT00307580","phase":"PHASE4","title":"Cathflo Activase Pediatric Study","status":"COMPLETED","sponsor":"Genentech, Inc.","startDate":"2002-04","conditions":"Dysfunctional Central Venous Access Devices (CVADS)","enrollment":300},{"nctId":"NCT00359424","phase":"PHASE3","title":"Interventional Management of Stroke (IMS) III Trial","status":"TERMINATED","sponsor":"Joseph Broderick","startDate":"2006-08","conditions":"Stroke","enrollment":656},{"nctId":"NCT01150266","phase":"PHASE1","title":"Study for the Use of Alteplase in Patients Who Awaken With Stroke","status":"WITHDRAWN","sponsor":"University of California, San Diego","startDate":"2011-08","conditions":"Ischemic Stroke","enrollment":""},{"nctId":"NCT01670474","phase":"PHASE4","title":"Prolonged Hemodialysis Catheter Survival With Copolymer Coating and Rt-PA","status":"UNKNOWN","sponsor":"Centre Hospitalier du Centre du Valais","startDate":"2011-01","conditions":"Malfunction; Catheter, Thrombosis, Mechanical Complication of Hemodialysis Catheter","enrollment":240},{"nctId":"NCT00468104","phase":"NA","title":"Efficacy and Safety of Activase (Ateplase) vs Placebo in Complicated Pleural Effusions (CPE)/Empyemas","status":"COMPLETED","sponsor":"Midwest Pulmonary and Critical Care","startDate":"2004-04","conditions":"Pleural Effusion Associated With Pulmonary Infection, Bacterial Pleural Effusion Other Than Tuberculosis","enrollment":100},{"nctId":"NCT01455935","phase":"PHASE2","title":"Wake up Symptomatic Stroke - Benefit of Intravenous Clot Busters or Endovascular Intervention","status":"UNKNOWN","sponsor":"Jacobs Neurological Institute","startDate":"2011-11","conditions":"Stroke","enrollment":90},{"nctId":"NCT00624000","phase":"NA","title":"IV vs. IA tPA (Activase) in Acute Ischemic Stroke With CTA Evidence of Major Vessel Occlusion","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2004-03","conditions":"Ischemic Stroke","enrollment":7},{"nctId":"NCT01098890","phase":"PHASE2","title":"Intraventricular Tissue Plasminogen Activator (tPA) in the Management of Aneurysmal Subarachnoid Hemorrhage","status":"UNKNOWN","sponsor":"University of Calgary","startDate":"2009-10","conditions":"Aneurysmal Subarachnoid Hemorrhage, Intraventricular Hemorrhage","enrollment":12},{"nctId":"NCT00250991","phase":"PHASE1, PHASE2","title":"Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke (CLEAR Stroke) Trial","status":"COMPLETED","sponsor":"University of Cincinnati","startDate":"2003-07","conditions":"Stroke","enrollment":94},{"nctId":"NCT00303420","phase":"PHASE4","title":"Alteplase for Blood Flow Restoration in Hemodialysis Catheters","status":"TERMINATED","sponsor":"University of Manitoba","startDate":"2004-09","conditions":"Thrombosis","enrollment":180}],"_emaApprovals":[],"_faersSignals":[{"count":1343,"reaction":"NO ADVERSE EVENT"},{"count":698,"reaction":"OFF LABEL USE"},{"count":310,"reaction":"PRODUCT STORAGE ERROR"},{"count":187,"reaction":"INTERCEPTED PRODUCT STORAGE ERROR"},{"count":161,"reaction":"INTERCEPTED MEDICATION ERROR"},{"count":117,"reaction":"DRUG INEFFECTIVE"},{"count":103,"reaction":"DEATH"},{"count":54,"reaction":"NAUSEA"},{"count":51,"reaction":"FATIGUE"},{"count":50,"reaction":"PYREXIA"}],"crossReferences":{"chemblId":"CHEMBL1201593"},"_approvalHistory":[{"date":"20050104","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA103172"},{"date":"20220901","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA103172"},{"date":"20150213","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA103172"},{"date":"20180228","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA103172"},{"date":"20020515","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA103172"},{"date":"19950403","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA103172"},{"date":"20010904","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA103172"},{"date":"19871113","type":"ORIG","sponsor":"GENENTECH","applicationNumber":"BLA103172"},{"date":"20201008","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA103172"},{"date":"20180228","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA103172"},{"date":"19960618","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA103172"},{"date":"20170630","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA103172"}],"publicationCount":9,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Cathflo Activase","genericName":"Cathflo Activase","companyName":"Memorial Healthcare System","companyId":"memorial-healthcare-system","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":1},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T04:52:03.913316+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}